In December 2024, Glutaraldehyde prices experienced a varied trend across key markets, largely influenced by the shifting dynamics of supply and demand in each region. The most notable changes were seen in the US market, where Glutaraldehyde prices surged significantly due to rising demand from downstream industries.

The expectation of Supply constraints and potential disruptions at US ports further contributed to this increase, as buyers rushed to procure additional stock before the anticipated strike. Negotiations between the International Longshoremen Association (ILA) and the United States Maritime Alliance (USMX) were still ongoing, and the uncertainty around these talks put additional pressure on inventory levels, pushing prices up by 2.13% during the month.

In contrast, the Chinese market saw a more stable but slightly declining trend for Glutaraldehyde prices. Prices dropped marginally by 0.93% in the FOB market. Demand from both domestic and international buyers remained steady, but the year-end period prompted domestic manufacturers and traders to offer substantial discounts on Glutaraldehyde. As many manufacturers worked to clear out excess inventory, the pressure to destock further contributed to the price drop. Despite this, the market sentiment remained relatively stable, and there was no significant disruption in demand from key sectors.

Meanwhile, in the Indian market, the Glutaraldehyde showed steady pricing, with only a marginal increase observed during the period. Demand from downstream industries remained positive, bolstered by steady supply conditions in the region. The availability of Glutaraldehyde was sufficient, and manufacturers took advantage of slight discounts during the year-end to replenish their stocks. Positive market sentiment and strategic stocking behavior further helped maintain price stability in India’s Glutaraldehyde market. Although the rise in funding for the pharmaceutical and healthcare sector in India was notable, it had a limited impact on Glutaraldehyde prices, which only increased by 0.4% during the month.

The surge in funding for the pharmaceutical and healthcare sectors across the globe, particularly in December 2024, had mixed effects on Glutaraldehyde prices. A dramatic increase of 1,440.84% in funding for these sectors reached $69.8 million, up from $4.53 million in November 2024. However, when compared to December 2023, there was a 6.93% decline in funding. The majority of this funding came from early-stage rounds, which accounted for 78.9% of the total investments, while late-stage and seed-stage investments contributed 13.9% and 7.3%, respectively. Despite this positive outlook for downstream sectors, Glutaraldehyde prices remained relatively muted in India, showing only a marginal increase during the period.